Cargando…

P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY

Detalles Bibliográficos
Autores principales: Hungria, Vania, Weisel, Katja, Currie, Brooke, Perera, Sue, Sule, Neal, He, Wei, Mckeown, Astrid, Sapra, Sandhya, Nelsen, Linda, LI, Mary, Barale, Sophie, Boyle, Julia, Mcpoyle, Kaytlyn, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431560/
http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae
_version_ 1785091230063919104
author Hungria, Vania
Weisel, Katja
Currie, Brooke
Perera, Sue
Sule, Neal
He, Wei
Mckeown, Astrid
Sapra, Sandhya
Nelsen, Linda
LI, Mary
Barale, Sophie
Boyle, Julia
Mcpoyle, Kaytlyn
Dimopoulos, Meletios A.
author_facet Hungria, Vania
Weisel, Katja
Currie, Brooke
Perera, Sue
Sule, Neal
He, Wei
Mckeown, Astrid
Sapra, Sandhya
Nelsen, Linda
LI, Mary
Barale, Sophie
Boyle, Julia
Mcpoyle, Kaytlyn
Dimopoulos, Meletios A.
author_sort Hungria, Vania
collection PubMed
description
format Online
Article
Text
id pubmed-10431560
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104315602023-08-17 P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY Hungria, Vania Weisel, Katja Currie, Brooke Perera, Sue Sule, Neal He, Wei Mckeown, Astrid Sapra, Sandhya Nelsen, Linda LI, Mary Barale, Sophie Boyle, Julia Mcpoyle, Kaytlyn Dimopoulos, Meletios A. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431560/ http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Hungria, Vania
Weisel, Katja
Currie, Brooke
Perera, Sue
Sule, Neal
He, Wei
Mckeown, Astrid
Sapra, Sandhya
Nelsen, Linda
LI, Mary
Barale, Sophie
Boyle, Julia
Mcpoyle, Kaytlyn
Dimopoulos, Meletios A.
P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
title P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
title_full P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
title_fullStr P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
title_full_unstemmed P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
title_short P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
title_sort p964: patient (pt)-reported outcomes in pts with relapsed/refractory multiple myeloma (rrmm) treated with belantamab mafodotin (belamaf) vs pomalidomide/low dose dexamethasone (pd) in the dreamm-3 study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431560/
http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae
work_keys_str_mv AT hungriavania p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT weiselkatja p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT curriebrooke p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT pererasue p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT suleneal p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT hewei p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT mckeownastrid p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT saprasandhya p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT nelsenlinda p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT limary p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT baralesophie p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT boylejulia p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT mcpoylekaytlyn p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study
AT dimopoulosmeletiosa p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study